Sanofi
Drugmakers to hike prices for 2021 as Covid pressure puts revenues at risk
Sanofi-GSK delay Covid-19 vaccine to late 2021 in setback to global fight
Sputnik V developers offer to share tech with Sanofi-GSK amid vaccine delay
Sanofi offers to buy Dutch biotechnology firm Kiadis for $358.4 million
Sanofi India: Long-term investors advised to consider the stock on dips

Sanofi, GSK to supply Covax with 200 million doses of coronavirus vaccine
Sanofi, GSK to provide 200 mn doses of Covid-19 vaccine to global alliance
World Coronavirus Dispatch: Students across globe returning to classrooms
Sanofi and GSK launch trial for protein-based coronavirus vaccine
Pick-up in biosimilar launches driving Biocon's prospects; stock rises 7.8%

Sanofi more confident about its coronavirus vaccines, trials next month
France's Sanofi SA to buy US-based Principia Biopharma for $3.7 billion
Sanofi snags US biotech asset with $3.7 bn deal for Principia Biopharma
French group Sanofi to buy US firm Principia Biopharma for $3.7 billion
US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'
Sanofi under investigation on charges including manslaughter over Depakine
European Union in talks to secure Sanofi deal for coronavirus vaccine
US to pay Sanofi, GSK $2.1 bn for Covid-19 vaccine to cover 50 mn people
US pledges up to $2.1 billion for Sanofi, GlaxoSmithKline Covid-19 vaccine
Sanofi lifts earnings view as Regeneron stake sale boosts second quarter